Mary B. Palascak

1.5k total citations
19 papers, 1.1k citations indexed

About

Mary B. Palascak is a scholar working on Physiology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mary B. Palascak has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 13 papers in Genetics and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mary B. Palascak's work include Erythrocyte Function and Pathophysiology (14 papers), Hemoglobinopathies and Related Disorders (13 papers) and Neonatal Health and Biochemistry (6 papers). Mary B. Palascak is often cited by papers focused on Erythrocyte Function and Pathophysiology (14 papers), Hemoglobinopathies and Related Disorders (13 papers) and Neonatal Health and Biochemistry (6 papers). Mary B. Palascak collaborates with scholars based in United States, Australia and Switzerland. Mary B. Palascak's co-authors include Robert S. Franco, Clinton H. Joiner, Robert M. Cohen, Peter Ciraolo, Paramjit K. Khera, Eric P. Smith, Christopher J. Lindsell, Donald L. Rucknagel, Zahida Yasin and Rafael Franco and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Mary B. Palascak

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary B. Palascak United States 16 493 426 319 236 233 19 1.1k
Bregt Roerdinkholder‐Stoelwinder Netherlands 12 945 1.9× 237 0.6× 363 1.1× 379 1.6× 24 0.1× 15 1.4k
Jan M. Werre Netherlands 9 619 1.3× 145 0.3× 175 0.5× 341 1.4× 21 0.1× 10 1.0k
Florinda Gilsanz Spain 18 386 0.8× 313 0.7× 334 1.0× 323 1.4× 13 0.1× 50 1.1k
Yvonne A. M. Groenen‐Döpp Netherlands 6 506 1.0× 120 0.3× 158 0.5× 306 1.3× 18 0.1× 8 802
GL Dale United States 13 351 0.7× 97 0.2× 478 1.5× 127 0.5× 20 0.1× 27 992
Chun‐Ming Pan China 16 75 0.2× 132 0.3× 355 1.1× 656 2.8× 176 0.8× 33 1.1k
Fred V. Plapp United States 13 98 0.2× 165 0.4× 293 0.9× 66 0.3× 53 0.2× 30 594
Yasushi Nakamoto Japan 18 95 0.2× 82 0.2× 152 0.5× 356 1.5× 57 0.2× 78 1.2k
Carla Casu United States 20 440 0.9× 1.1k 2.5× 1.1k 3.4× 310 1.3× 9 0.0× 50 1.7k
Bernard Silver United States 13 58 0.1× 118 0.3× 252 0.8× 398 1.7× 97 0.4× 21 1.1k

Countries citing papers authored by Mary B. Palascak

Since Specialization
Citations

This map shows the geographic impact of Mary B. Palascak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary B. Palascak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary B. Palascak more than expected).

Fields of papers citing papers by Mary B. Palascak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary B. Palascak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary B. Palascak. The network helps show where Mary B. Palascak may publish in the future.

Co-authorship network of co-authors of Mary B. Palascak

This figure shows the co-authorship network connecting the top 25 collaborators of Mary B. Palascak. A scholar is included among the top collaborators of Mary B. Palascak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary B. Palascak. Mary B. Palascak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Palascak, Mary B., et al.. (2015). Activation of protein kinase C by phorbol ester increases red blood cell scramblase activity and external phosphatidylserine. European Journal Of Haematology. 95(5). 405–410. 5 indexed citations
2.
Khera, Paramjit K., Eric P. Smith, Christopher J. Lindsell, et al.. (2014). Use of an oral stable isotope label to confirm variation in red blood cell mean age that influences HbA1c interpretation. American Journal of Hematology. 90(1). 50–55. 31 indexed citations
3.
Wojton, Jeffrey, Zhengtao Chu, Haritha Mathsyaraja, et al.. (2013). Systemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against Glioblastoma. Molecular Therapy. 21(8). 1517–1525. 46 indexed citations
4.
Chu, Zhengtao, Shadi Abu‐Baker, Mary B. Palascak, et al.. (2013). Targeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer. PLoS ONE. 8(10). e75507–e75507. 37 indexed citations
5.
Franco, Robert S., Estela Puchulu‐Campanella, Mary B. Palascak, et al.. (2012). Changes in the properties of normal human red blood cells during in vivo aging. American Journal of Hematology. 88(1). 44–51. 86 indexed citations
6.
Srinivasan, Ramprasad, Yascha W. van den Berg, Bruce J. Aronow, et al.. (2011). Splice variants of tissue factor promote monocyte‐endothelial interactions by triggering the expression of cell adhesion molecules via integrin‐mediated signaling. Journal of Thrombosis and Haemostasis. 9(10). 2087–2096. 55 indexed citations
7.
Palascak, Mary B., et al.. (2009). Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations. British Journal of Haematology. 146(4). 447–455. 19 indexed citations
8.
Franco, Robert S., et al.. (2008). Cyclical Changes in Erythrocyte Characteristics during Chronic Transfusion Therapy in Pediatric Sickle Cell Patients. Blood. 112(11). 4792–4792. 1 indexed citations
9.
Cohen, Robert M., Robert S. Franco, Paramjit K. Khera, et al.. (2008). Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood. 112(10). 4284–4291. 340 indexed citations
10.
Franco, Robert S., Zahida Yasin, Mary B. Palascak, et al.. (2006). The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood. 108(3). 1073–1076. 86 indexed citations
11.
Yasin, Zahida, Scott R. Witting, Mary B. Palascak, et al.. (2003). Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood. 102(1). 365–370. 92 indexed citations
13.
Franco, Robert S., Zahida Yasin, Mary B. Palascak, et al.. (2000). The survival characteristics of dense sickle cells. Blood. 96(10). 3610–3617. 3 indexed citations
14.
Franco, Robert S., Zahida Yasin, Mary B. Palascak, et al.. (2000). The survival characteristics of dense sickle cells. Blood. 96(10). 3610–3617. 39 indexed citations
15.
Franco, Rafael, et al.. (1998). Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells.. Journal of Clinical Investigation. 101(12). 2730–2740. 68 indexed citations
19.
Franco, Rafael, et al.. (1995). KCl cotransport activity in light versus dense transferrin receptor-positive sickle reticulocytes.. Journal of Clinical Investigation. 95(6). 2573–2580. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026